William Harris Investors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

William Harris Investors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12K	Hold	31,621	–	–	﹤0.01%	95
2016 Q3	$9K	Hold	31,621	–	–	﹤0.01%	89
2016 Q2	$7K	Hold	31,621	–	–	﹤0.01%	94
2016 Q1	$4K	Hold	31,621	–	–	﹤0.01%	95
2015 Q4	$4K	Sell	31,621 -681	-2%	-$96	﹤0.01%	89
2015 Q3	$6K	Hold	32,302	–	–	﹤0.01%	89
2015 Q2	$23K	Hold	32,302	–	–	0.01%	87
2015 Q1	$22K	Hold	32,302	–	–	0.01%	85
2014 Q4	$26K	Hold	32,302	–	–	0.01%	81
2014 Q3	$15K	Hold	32,302	–	–	﹤0.01%	80
2014 Q2	$16K	Hold	32,302	–	–	﹤0.01%	84
2014 Q1	$10K	Hold	32,302	–	–	﹤0.01%	85
2013 Q4	$11K	Hold	32,302	–	–	﹤0.01%	86
2013 Q3	$65K	Hold	32,302	–	–	0.02%	89
2013 Q2	$61K	Buy	+32,302	New	+$56.7K	0.02%	87

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

William Harris Investors's GCVRZ Position: Q4 2016 in Review

William Harris Investors held its Sanofi Contingent Value Rights (GCVRZ) position steady in Q4 2016 at 31,621 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #95.

William Harris Investors first reported a position in GCVRZ in Q2 2013 and has held it in 15 quarters since. The position peaked at $65K in Q3 2013. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.

William Harris Investors held 31,621 shares of Sanofi Contingent Value Rights worth $12K as of Q4 2016.
William Harris Investors left its Sanofi Contingent Value Rights share count unchanged in Q4 2016.
Sanofi Contingent Value Rights made up ﹤0.01% of William Harris Investors's portfolio in Q4 2016, its #95 holding.
William Harris Investors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and has held it in 15 quarters since.
William Harris Investors's Sanofi Contingent Value Rights position peaked at $65K in Q3 2013.
120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.

Based on William Harris Investors's 13F filing for Q4 2016, filed 7 Feb 2017.